Agenus to participate at b riley securities' 2023 virtual oncology conference

Lexington, mass., jan. 10, 2023 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with a broad pipeline targeting cancer and infectious disease, today announced that dr. garo armen, chairman and ceo of agenus, and dr. steven o'day, chief medical officer, will participate in a virtual fireside chat at the b riley securities' 2023 virtual oncology conference on wednesday, january 18th at 11:30am et.
AGEN Ratings Summary
AGEN Quant Ranking